Priority
Focus
–
Kidney
Cancer
Editorial
by
Jed-Sian
Cheng
and Michael
L.
Blute
on
pp.
73–74
of
this
issue
Minimally
Invasive
Partial Nephrectomy Versus
Laparoscopic
Cryoablation
for
Patients Newly Diagnosed with
a
Single
Small
Renal Mass
Nicola
Fossati
a , b , * ,Alessandro
Larcher
a ,Giulio M.
Gadda
a ,Daniel D.
Sjoberg
b ,Francesco
A. Mistretta
a ,Paolo Dell’Oglio
a ,Giuliana
Lista
a ,Cristina
Carenzi
a ,Giovanni
Lughezzani
c ,Massimo
Lazzeri
c ,Francesco Montorsi
a ,Andrew
J.
Vickers
b ,Giorgio
Guazzoni
c ,Nicolo` Maria
Buffi
ca
Division of Oncology
/ Unit of Urology, URI,
IRCCS Ospedale San Raffaele – Ville Turro, Milan,
Italy;
b
Department of Epidemiology and Biostatistics, Memorial
Sloan-Kettering
Cancer
Center, New
York, NY, USA;
c
Department
of Urology, Humanitas
Clinical
and
Research Center, Humanitas University, Milan –
Italy
E U R O P E A N U R O L O G Y F O C U S 1 ( 2 0 1 5 ) 6 6 – 7 2available
at
www.sciencedirect.comjournal
homepage:
www.europeanurology.comArticle
info
Article
history:
Accepted
February
4,
2015
Associate
Editor:
Tobias
Klatte
Keywords:
Small
renal mass
Minimally
invasive
surgery
Partial
nephrectomy
Cryosurgery
Abstract
Background:
Minimally
invasive
partial
nephrectomy
(MIPN)
and
laparoscopic
renal
cryoa-
blation
(LRC)
are
two
treatment
options
increasingly
used
for
small
renal masses.
Objective:
To compare perioperative, oncologic, and
functional outcomes after MIPN and LRC.
Design,
setting,
and
participants:
We
included
372
consecutive
patients
newly
diagnosed
with
a
single
small
renal mass
and
treated with
either MIPN
or
LRC
at
a
single
institution.
Intervention:
MIPN
and
LRC.
Outcome measurements and
statistical analysis:
Regressionmodels were used to evaluate the
impact of surgical treatment (MIPNvs LRC) onperioperative, oncologic, and functional outcomes.
Results
and
limitations:
Overall,
206
patients
(55%)
underwent MIPN
and
166
(45%) were
treated
with
LRC.
In
multivariate
analysis,
the
rate
of
postoperative
complications
was
significantly
lower
in
the MIPN
compared
to
the
LRC
group
(20%
vs 28%;
adjusted difference
–11%;
p
= 0.02) after adjusting
for age at
surgery, American Society of Anesthesiologists
score
(1
vs
2
vs
3),
and
tumor
size.
The median
follow-up was
similar
in
the
two
groups
(43
and
39 mo
for MIPN
and
LRC,
respectively).
In univariate Cox
regression
analysis,
treatment
type
was not
significantly associated with disease-free
survival
(hazard
ratio 1.06, 95%
confidence
interval
[CI] 0.45–2.52;
p
= 0.9). The disease-free survival rate at 5 yr was 92%
in MIPN and 93%
in
LRC
patients.
In multivariate
linear
regression
analysis,
LRC was
significantly
associated
with
a
higher
estimated
glomerular
filtration
rate
(eGFR)
at
6
mo
compared
to
MIPN
(coefficient
4.68,
95%
CI
0.06–9.30;
p
= 0.047)
after
adjusting
for
age
at
surgery,
tumor
size,
and preoperative
eGFR. There was no
significant
association between
surgical
treatment
and
postoperative
eGFR
at
3
yr
after
surgery
(coefficient
–2.36,
95%
CI
–7.55
to
2.83;
p
= 0.4).
Limitations
include
the
retrospective
study
design
and
selection
bias.
Conclusions:
MIPN and LRC provided
similar cancer control and comparable
renal
function at
intermediate-term
follow-up. Both
surgical
techniques
emerged
as
viable
treatment
options
for patient newly diagnosed with a single small renal mass. Further multi-institutional studies
with
longer
follow-up
and
nephrometry
scores
are
needed
to
corroborate
our
findings.
Patient
summary:
In
patients
newly
diagnosed with
a
single
small
renal mass, minimally
invasive
partial
nephrectomy
and
laparoscopic
renal
cryoablation
provided
similar
cancer
control
and
comparable
renal
function
at
intermediate-term
follow-up.
#
2015
European
Association
of Urology.
Published
by
Elsevier
B.V.
All
rights
reserved.
* Corresponding
author. Division of Oncology
/ Unit
of Urology,
IRCCS Ospedale
San Raffaele – Ville
Turro,
Vita-Salute
San
Raffaele University,
Via
Stamira
d’Ancona,
20,
20127 Milan,
Italy.
Tel.
+39
02
26433357;
Fax:
+39
02
26433442.
address:
nicola.fossati@gmail.com(N.
Fossati).
http://dx.doi.org/10.1016/j.euf.2015.02.0022405-4569/
#
2015
European
Association
of Urology.
Published
by
Elsevier
B.V.
All
rights
reserved.




